Association of variants in gastric inhibitory polypeptide receptor gene with impaired glucose homeostasis in obese children and adolescents from Berlin

European Journal of Endocrinology

Volumn 163, Issue 2, 2010, Pages 259-264

  Sauber, Jeannine ^a   Grothe, Jessica ^a   Behm, Maria ^a   Scherag, André ^b   Grallert, Harald ^c   Illig, Thomas ^c   Hinney, Anke ^b   Hebebrand, Johannes ^b   Wiegand, Susanna ^a   Grüters, Annette ^a   Krude, Heiko ^a   Biebermann, Heike ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GENOMIC DNA; HORMONE RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BODY MASS; CHILD; CHILDHOOD; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC SCREENING; GENOTYPE; GERMANY; GLUCOSE HOMEOSTASIS; HUMAN; IMPAIRED GLUCOSE HOMEOSTASIS; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; OBESITY; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RECEPTOR GENE; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ALLELES; BLOOD GLUCOSE; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; GERMANY; GLUCOSE INTOLERANCE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; MALE; MUTATION; OBESITY; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GASTROINTESTINAL HORMONE;

EID: 77955349970     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-10-0444     Document Type: Article

References (31)

1. Yip RG & Wolfe MM. GIP biology and fat metabolism. Life Sciences 2000 66 91-103.
2. Rudovich N, Kaiser S, Engeli S, Osterhoff M, Gogebakan O, Bluher M & Pfeiffer AF. GIP receptor mRNA expression in different fat tissue depots in postmenopausal non-diabetic women. Regulatory Peptides 2007 142 138-145. (Pubitemid 46899243)
3. Miyawaki K, Yamada Y, Ban N, Ihara Y, Tsukiyama K, Zhou H, Fujimoto S, Oku A, Tsuda K, Toyokuni S, Hiai H, Mizunoya W, Fushiki T, Holst JJ, Makino M, Tashita A, Kobara Y, Tsubamoto Y, Jinnouchi T, Jomori T & Seino Y. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nature Medicine 2002 8 738-742.
4. Yamada Y & Seino Y. Physiology of GIP - a lesson from GIP receptor knockout mice. Hormone and Metabolic Research 2004 36 771-774.
5. Getty-Kaushik L, Song DH, Boylan MO, Corkey BE & Wolfe MM. Glucose-dependent insulinotropic polypeptide modulates adipocyte lipolysis and reesterification. Obesity 2006 14 1124-1131.
6. McClean PL, Irwin N, Cassidy RS, Holst JJ, Gault VA & Flatt PR. GIP receptor antagonism reverses obesity, insulin resistance, and associated metabolic disturbances induced in mice by prolonged consumption of high-fat diet. American Journal of Physiology. Endocrinology and Metabolism 2007 293 E1746-E1755. (Pubitemid 350255128)
7. Hansotia T, Maida A, Flock G, Yamada Y, Tsukiyama K, Seino Y & Drucker DJ. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. Journal of Clinical Investigation 2007 117 143-152.
8. Fulurija A, Lutz TA, Sladko K, Osto M,Wielinga PY, Bachmann MF & Saudan P. Vaccination against GIP for the treatment of obesity. PLoS ONE 2008 3 e3163.
9. Irwin N, McClean PL, Cassidy RS, O'Harte FP, Green BD, Gault VA, Harriott P & Flatt PR. Comparison of the anti-diabetic effects of GIP- and GLP-1-receptor activation in obese diabetic (ob/ob) mice: studies with DPP IV resistant N-AcGIP and exendin(1-39)amide. Diabetes/Metabolism Research and Reviews 2007 23 572-579.
10. Saxena R, Hivert MF, Langenberg C, Tanaka T, Pankow JS, Vollenweider P, Lyssenko V, Bouatia-Naji N, Dupuis J, Jackson AU, Kao WH, Li M, Glazer NL, Manning AK, Luan J, Stringham HM, Prokopenko I, Johnson T, Grarup N, Boesgaard TW, Lecoeur C, Shrader P, O'Connell J, Ingelsson E, Couper DJ, Rice K, Song K, Andreasen CH, Dina C, Kottgen A, Le Bacquer O, Pattou F, Taneera J, Steinthorsdottir V, Rybin D, Ardlie K, Sampson M, Qi L, van Hoek M, Weedon MN, Aulchenko YS, Voight BF, Grallert H, Balkau B, Bergman RN, Bielinski SJ, Bonnefond A, Bonnycastle LL, Borch-Johnsen K, Bottcher Y, Brunner E, Buchanan TA, Bumpstead SJ, Cavalcanti-Proenca C, Charpentier G, Chen YD, Chines PS, Collins FS, Cornelis M, Crawford JG, Delplanque J, Doney A, Egan JM, Erdos MR, Firmann M, Forouhi NG, Fox CS, Goodarzi MO, Graessler J, Hingorani A, Isomaa B, Jorgensen T, Kivimaki M, Kovacs P, Krohn K, Kumari M, Lauritzen T, Levy-Marchal C, Mayor V, McAteer JB, Meyre D, Mitchell BD, Mohlke KL, Morken MA, Narisu N, Palmer CN, Pakyz R, Pascoe L, Payne F, Pearson D, Rathmann W, Sandbaek A, Sayer AA, Scott LJ, Sharp SJ, Sijbrands E, Singleton A, Siscovick DS, Smith NL, Sparso T, Swift AJ, Syddall H, Thorleifsson G, Tonjes A, Tuomi T, Tuomilehto J, Valle TT, Waeber G, Walley A, Waterworth DM, Zeggini E, Zhao JH, Illig T, Wichmann HE, Wilson JF, van Duijn C, Hu FB, Morris AD, Frayling TM, Hattersley AT, Thorsteinsdottir U, Stefansson K, Nilsson P, Syvanen AC, Shuldiner AR, Walker M, Bornstein SR, Schwarz P, Williams GH, Nathan DM, Kuusisto J, Laakso M, Cooper C, Marmot M, Ferrucci L, Mooser V, Stumvoll M, Loos RJ, Altshuler D, Psaty BM, Rotter JI, Boerwinkle E, Hansen T, Pedersen O, Florez JC, McCarthy MI, Boehnke M, Barroso I, Sladek R, Froguel P, Meigs JB, Groop L, Wareham NJ & Watanabe RM. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nature Genetics 2010 42 142-148.
11. Nitz I, Fisher E, Weikert C, Burwinkel B, Li Y, Mohlig M, Boeing H, Schreiber S, Schrezenmeir J & Doring F. Association analyses of GIP and GIPR polymorphisms with traits of the metabolic syndrome. Molecular Nutrition & Food Research 2007 51 1046-1052. (Pubitemid 47292278)
12. Vogel CI, Scherag A, Bronner G, Nguyen TT, Wang HJ, Grallert H, Bornhorst A, Rosskopf D, Volzke H, Reinehr T, Rief W, Illig T, Wichmann HE, Schafer H, Hebebrand J & Hinney A. Gastric inhibitory polypeptide receptor: association analyses for obesity of several polymorphisms in large study groups. BMC Medical Genetics 2009 10 19.
13. Bau AM, Ernert A, Schenk L, Wiegand S, Martus P, Gruters A & Krude H. Is there a further acceleration in the age at onset of menarche? A cross-sectional study in 1840 school children focusing on age and bodyweight at the onset of menarche European Journal of Endocrinology 2009 160 107-113.
14. Kromeyer-Hauschild K, Wabitsch M, Kunze D, Geller F, Geib HC, Hesse V, von Hippel A, Jaeger U, Johnsen D, Korte W, Menner K, Müller G, Müller JM, Niemann-Pilatus A, Remer T, Schaefer F, Wittchen HU, Zabransky S, Zellner K, Ziegler A & Hebebrand J. Perzentile für den Bodymass-Index für das Kindes- und Jugendalter unter Heranziehung verschiedener deutscher Stichproben. Monatsschrift für Kinderheilkunde 2001 149 807-818.
15. Cole TJ. The LMS method for constructing normalized growth standards. European Journal of Clinical Nutrition 1990 44 45-60.
16. Cole TJ, Bellizzi MC, Flegal KM & Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000 320 1240-1243.
17. Wabitsch M & Moß A. Evidenzbasierte Leitlinie der Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter und der beteiligten medizinischen-wissenschaftlichen Fachgesellschaften, Berufsverbände und weitere Organisationen.: Arbeitsgemeinschaft Adipositas im Kindes- und Jugendalter (AGA) www.a-g-a.de, 2009.
18. Allard P, Delvin EE, Paradis G, Hanley JA, O'Loughlin J, Lavallee C, Levy E & Lambert M. Distribution of fasting plasma insulin, free fatty acids, and glucose concentrations and of homeostasis model assessment of insulin resistance in a representative sample of Quebec children and adolescents. Clinical Chemistry 2003 49 644-649.
19. Rozen S & Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods in Molecular Biology 2000 132 365-386.
20. Moss A, Wabitsch M, Kromeyer-Hauschild K, Reinehr T & Kurth BM. Prevalence of overweight and adiposity in German school children. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2007 50 1424-1431.
21. Ozer BK. Growth reference centiles and secular changes in Turkish children and adolescents. Economics and Human Biology 2007 5 280-301. (Pubitemid 46876316)
22. Smit MJ, Vischer HF, Bakker RA, Jongejan A, Timmerman H, Pardo L & Leurs R. Pharmacogenomic and structural analysis of constitutive g protein-coupled receptor activity. Annual Review of Pharmacology and Toxicology 2007 47 53-87.
23. Tseng CC & Lin L. A point mutation in the glucose-dependent insulinotropic peptide receptor confers constitutive activity. Biochemical and Biophysical Research Communications 1997 232 96-100. (Pubitemid 27211927)
24. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A & Hebebrand J. Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. American Journal of Human Genetics 2004 74 572-581.
25. Xiang Z, Litherland SA, Sorensen NB, Proneth B, Wood MS, Shaw AM, Millard WJ & Haskell-Luevano C. Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin- derived agonists and the agouti-related protein (AGRP) antagonist. Biochemistry 2006 45 7277-7288.
26. Rosmond R, Chagnon M, Bouchard C & Bjorntorp P. A missense mutation in the human melanocortin-4 receptor gene in relation to abdominal obesity and salivary cortisol. Diabetologia 2001 44 1335-1338. (Pubitemid 33010512)
27. Gu W, Tu Z, Kleyn PW, Kissebah A, Duprat L, Lee J, Chin W, Maruti S, Deng N, Fisher SL, Franco LS, Burn P, Yagaloff KA, Nathan J, Heymsfield S, Albu J, Pi-Sunyer FX & Allison DB. Identification and functional analysis of novel human melanocortin-4 receptor variants. Diabetes 1999 48 635-639.
28. Heid IM, Vollmert C, Kronenberg F, Huth C, Ankerst DP, Luchner A, Hinney A, Bronner G, Wichmann HE, Illig T, Doring A & Hebebrand J. Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study. Obesity 2008 16 369-376.
29. Tseng CC, Zhang XY & Wolfe MM. Effect of GIP and GLP-1 antagonists on insulin release in the rat. American Journal of Physiology 1999 276 E1049-E1054.
30. Walley AJ, Asher JE & Froguel P. The genetic contribution to nonsyndromichumanobesity. Nature Reviews.Genetics200910431-442.
31. Kleinau G, Brehm M, Wiedemann U, Labudde D, Leser U & Krause G. Implications for molecular mechanisms of glycoprotein hormone receptors using a new sequence-structure-function analysis resource. Molecular Endocrinology 2007 21 574-580. (Pubitemid 46184903)